EDX Medical Group PLC (LSE:EDX) Share Price

Company Profile

Business description
EDX Medical Group PLC is principally engaged in the business of creating health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development, and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical goods segment. Geographically, all revenue was derived from the United Kingdom.
Contact
Milton Road
211 Cambridge Science Park
CambridgeCB4 0WA
GBR
https://www.edxmedical.co.uk
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
Employees
15

Recommended

Sales growth but lack of margin expansion due to competition.

Johannes Faul, CFA | 15 June 2026

Discounted Aussie shares that offer a tax rebate.

Tyger Fitzpatrick | 14 June 2026

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Tom Lauricella | 14 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,128.00	14.60	0.16%
CAC 40	8,384.01	33.14	0.40%
DAX 40	24,894.01	258.71	1.05%
Dow JONES (US)	51,671.03	468.77	0.92%
FTSE 100	10,430.62	41.10	-0.39%
HKSE	24,842.67	124.57	0.50%
NASDAQ	26,683.94	795.10	3.07%
Nikkei 225	69,317.50	3,297.46	4.99%
NZX 50 Index	13,360.59	33.28	-0.25%
S&P 500	7,554.29	122.83	1.65%
S&P/ASX 200	8,914.00	7.00	0.08%
SSE Composite Index	4,096.47	64.96	1.61%